Aaron R. Hansen, BSc, MBBS, FRACP, highlights key findings from the theraPb trial, exploring the safety and preliminary efficacy of ADVC001 in mCRPC.
Aaron R. Hansen, BSc, MBBS, FRACP
Advertisement
Articles by Aaron R. Hansen, BSc, MBBS, FRACP
212Pb-ADVC001 is a PSMA-targeted alpha-emitting radioligand therapy.
Advertisement
Latest Updated Articles
Aaron Hansen, MD, shares key findings from the theraPb trial in mCRPCPublished: November 12th 2025 | Updated:
Advertisement
Advertisement
